EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study



Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study



Hepato-Gastroenterology 55(86-87): 1754-1759



Aflatoxin B1 (AFB1) is an important food-borne mycotoxin. The co-contamination of foodstuffs with this mycotoxin is well known and has been possibly implicated in the development of hepatocellular carcinoma in high risk regions around the world. This study investigates the serum aflatoxin B1 in patients with hepatocellular carcinoma and compares it to a control group. From January 2005 to January 2006, 80 cases with hepatocellular carcinoma diagnosed in the Gastroenterology center, Mansoura University, Egypt and 20 healthy subjects used as a control group were enrolled in the study. All patients were evaluated for age, sex, residence, occupation, history of other medical diseases, anti-bilharzial treatment, blood transfusion, viral markers, liver functions and serum level of aflatoxin B1. The mean age of our patients was 52.88 +/- 7.27 years versus 53.17 +/- 6.78 years for the controls, p>0.05. The serum level of AFP1 was highly significant in HCC patients compared with control (32.47 +/- 92.46 versus 7.33 +/- 5.5 P<0.0001) and it was statistically high between 51:60-years-old (P<0.05). Males represented 82.5% of the patients versus 17.5% for females. AFB1 was higher in males compared with females (P<0.05), higher in rural residents compared with urban residents (P<0.05), higher in Kafer Elchek government are versus others (P<0.01) and higher in farmers compared with those with other occupations (P<0.05). The serum level of AFB1 was high among patients with a history of anti-bilharzial treatment with tarar emetic versus oral treatment by Brazequantil (P<0.05). Hepatitis C antibody was positive in 70% of the patients. The serum level of AFB1 was statistically high in HCV-positive patients compared with HCV-negative ones (P<0.05) but showed no statistical significance in HBs-positive patients compared with HBs-negative ones (P>0.05). The serum level of AFB1 was statistically high in Child class B patients compared with class A (P<0.05), high in patients with tumor size > 5 cm compared with tumor size < 5 cm (P<0.05), high in right lobe tumor patients compared with left lobe tumor (P>0.05), high in multifocal hepatoma patients compared with single lesion patients (P<0.05). The serum level of AFB1 showed a statistically significant positive correlation with serum SGPT and alpha-fetoprotein. Aflatoxin B1 may play an important role in the occurrence of HCC in the north Nile delta area and especially in males, farmers, and rural residents, HCV infection, cirrhotic liver and multifocal hepatoma patients. Aflatoxin B1 in high concentration is associated with high incidence of chronic HCV, and affects hepatic parenchyma and multifocal lesions.

(PDF emailed within 1 workday: $29.90)

Accession: 051408475

Download citation: RISBibTeXText

PMID: 19102385



Related references

Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center Study. Hepato Gastroenterology: 86 87, 1754-1759, 2008

Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center. Hepato-Gastroenterology 54(73): 157-162, 2007

Hepatocellular carcinoma in Mansoura-Egypt: experience of 385 patients at a single center. Hepato-Gastroenterology 47(33): 663-668, 2000

A visit to Mansoura Urology & Nephrology Center, Mansoura, Egypt. Arab Journal of Urology 10(4): 445-446, 2012

Hepatocellular carcinoma in Egypt: a single center study over a decade. World Journal of Gastroenterology 11(33): 5193-5198, 2005

Prevalence of hepatocellular carcinoma in chronic hepatitis C patients in Mid Delta, Egypt: A single center study. Journal of the Egyptian National Cancer Institute 28(4): 257-262, 2016

Studies on culicini larvae in Mansoura Center, Dakahlia Governorate, Egypt. Journal of the Egyptian Society of Parasitology 28(3): 839-847, 1999

Aflatoxins as risk factors for hepatocellular carcinoma in humans. Cancer Research 52(7 Suppl): 2114s-2118s, 1992

Phenotype-genotype updates from familial Mediterranean fever database registry of Mansoura University Children' Hospital, Mansoura, Egypt. Indian Journal of Human Genetics 20(1): 43-50, 2014

Aflatoxins as risk factors for primary hepatocellular carcinoma in humans. Pennington Center nutrition series(1): 3-17, 1991

Prevalence and epidemiological features of hepatocellular carcinoma in Egypt-a single center experience. Hepatology Research 19(2): 170-179, 2001

Population-attributable risk of dietary aflatoxins and hepatitis B virus infection with respect to hepatocellular carcinoma. Nutrition and Cancer 48(1): 15-21, 2004

Evaluation of bone mineral density in children with hemophilia: Mansoura University children hospital (MUCH) experience, Mansoura, Egypt. Hematology 12(5): 431-437, 2007

Application of Probabilistic Modeling to Quantify the Reduction Levels of Hepatocellular Carcinoma Risk Attributable to Chronic Aflatoxins Exposure. Nutrition and Cancer 69(1): 1-13, 2016

Infection with the hepatitis C virus as a risk factor of cardiovascular events in the early years after renal transplantation: a single center study from Egypt. Saudi Journal of Kidney Diseases and Transplantation 23(6): 1268-1273, 2013